Design of nitric oxide synthase inhibitors and their use to reverse hypotension associated with cancer immunotherapy
- 31 December 1997
- journal article
- review article
- Published by Elsevier in Advances in Enzyme Regulation
- Vol. 37, 171-194
- https://doi.org/10.1016/s0065-2571(96)00008-8
Abstract
No abstract availableKeywords
This publication has 62 references indexed in Scilit:
- Selective Targeting of Nitric Oxide Synthase Inhibitors to System y+ in Activated MacrophagesBiochemical and Biophysical Research Communications, 1994
- Association between biosynthesis of nitric oxide and changes in immunological and vascular parameters in patients treated with interleukin-2European Journal of Clinical Investigation, 1994
- Diffusion of Nitric Oxide in the Aorta Wall Monitored in Situ by Porphyrinic MicrosensorsBiochemical and Biophysical Research Communications, 1993
- Modification of Energy Metabolism and Radiation Response of a Murine Tumor by Changes in Nitric Oxide AvailabilityBiochemical and Biophysical Research Communications, 1993
- Inactivation of macrophage nitric oxide synthase activity by NG-Methyl-L-arginineBiochemical and Biophysical Research Communications, 1991
- Reversal of endotoxin-mediated shock by NG-methyl-L-arginine, an inhibitor of nitric oxide synthesisBiochemical and Biophysical Research Communications, 1990
- NG-methylarginine, and inhibitor of endothelium-derived nitric oxide synthesis, is a potent pressor agent in the guinea pig: Does nitric oxide regulate blood pressure in vivo?Biochemical and Biophysical Research Communications, 1989
- Nitric oxide: A cytotoxic activated macrophage effector moleculeBiochemical and Biophysical Research Communications, 1988
- Observations on the Systemic Administration of Autologous Lymphokine-Activated Killer Cells and Recombinant Interleukin-2 to Patients with Metastatic CancerNew England Journal of Medicine, 1985
- The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholineNature, 1980